Morphological and functional changes in P-glycoprotein during dexamethasone-induced hepatomegaly

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 4, 2007, Pages 296-303

  Micuda, Stanislav ^a,b   Fuksa, Leos ^b   Mundlova, Lucie ^b   Osterreicher, Jan ^b   Mokry, Jaroslav ^b   Cermanova, Jolana ^b   Brcakova, Eva ^b   Staud, Frantisek ^c   Pokorna, Pavla ^b   Martinkova, Jirina ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^c UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Dexamethasone; Induction; P glycoprotein; Rhodamine 123; Steatosis

Indexed keywords

DEXAMETHASONE; GLYCOPROTEIN P; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; EVALUATION; HEPATOMEGALY; IMMUNOHISTOCHEMISTRY; LIVER WEIGHT; MALE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STEADY STATE; WESTERN BLOTTING; ZONATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY LIVER; GLUCOCORTICOIDS; HEPATOMEGALY; IMMUNOCHEMISTRY; INTUBATION, GASTROINTESTINAL; KIDNEY; LIVER; METABOLIC CLEARANCE RATE; MICROSCOPY, POLARIZATION; ORGAN SIZE; P-GLYCOPROTEINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINE 123; RNA, MESSENGER; WEIGHT LOSS;

EID: 33846959143     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04558.x     Document Type: Article

References (37)

1. Brady JM, Cherrington NJ, Hartley DP, Buist SC, Li N, Klaassen CD. Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab. Dispos. 2002; 30: 838-44.
2. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview. Adv. Drug Deliv. Rev. 2003; 55: 3-29.
3. Woodland C, Ito S, Koren G. A model for the prediction of digoxin-drug interactions at the renal tubular cell level. Ther. Drug Monit. 1998; 20: 134-8.
4. Kakumoto M, Takara K, Sakaeda T, Tanigawara Y, Kita T, Okumura K. MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs. Biol. Pharm. Bull. 2002; 25: 1604-7.
5. Lin JH. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv. Drug Deliv. Rev. 2003; 55: 53-81.
6. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab. Rev. 2004; 36: 57-104.
7. Shimada T, Terada A, Yokogawa K et al. Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy. Transplantation 2002; 74: 1419-24.
8. Anglicheau D, Flamant M, Schlageter MH et al. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol. Dial. Transplant. 2003; 18: 2409-14.
9. van Duijnhoven EM, Boots JM, Christiaans MH, Stolk LM, Undre NA, van Hooff JP. Increase in tacrolimus trough levels after steroid withdrawal. Transplant. Int. 2003; 16: 721-5.
10. Demeule M, Jodoin J, Beaulieu E, Brossard M, Beliveau R. Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett. 1999; 442: 208-14.
11. Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone. Drug Metab. Dispos. 2001; 29: 145-51.
12. Mei Q, Richards K, Strong-Basalyga K et al. Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2. J. Pharm. Sci. 2004; 93: 2488-96.
13. Kawahara M, Sakata A, Miyashita T, Tamai I, Tsuji A. Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice. J. Pharm. Sci. 1999; 88: 1281-7.
14. Micuda S, Mundlova L, Mokry J et al. The effect of Mdr1 induction on the pharmacokinetics of rhodamine 123 in rats. Basic Clin. Pharmacol. Toxicol. 2005; 96: 257-8.
15. Thatcher NJ, Caldwell J. Origins of hepatomegaly produced by dexamethasone (DEX), pregnenolone 16 alpha-carbonitrile (PCN) and phenobarbitone (PB) in female Sprague-Dawley rats. Biochem. Soc. Trans. 1994; 22: 132S.
16. Verrips A, Rotteveel JJ, Lippens R. Dexamethasone-induced hepatomegaly in three children. Pediatr. Neurol. 1998; 19: 388-91.
17. Dourakis SP, Sevastianos VA, Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. Am. J. Gastroenterol. 2002; 97: 1074-5.
18. Candelli M, Nista EC, Pignataro G et al. Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation. J. Intern. Med. 2003; 253: 391-2.
19. Iancu TC, Shiloh H, Dembo L. Hepatomegaly following short-term high-dose steroid therapy. J. Pediatr. Gastroenterol. Nutr. 1986; 5: 41-6.
20. Kunihara M, Nagai J, Murakami T, Takano M. Renal excretion of rhodamine 123, a P-glycoprotein substrate, in rats with glycerol-induced acute renal failure. J. Pharm. Pharmacol. 1998; 50: 1161-5.
21. Novotna M, Libra A, Kopecky M et al. P-Glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod. Toxicol. 2004; 18: 785-92.
22. Yokogawa K, Shimada T, Higashi Y et al. Modulation of mdr1a and CYP3A gene expression in the intestine and liver as possible cause of changes in the cyclosporin A disposition kinetics by dexamethasone. Biochem. Pharmacol. 2002; 63: 777-83.
23. Ghanem CI, GomeZ PC, Arana MC et al. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Biochem. Pharmacol. 2004; 68: 791-8.
24. Kageyama M, Namiki H, Fukushima H et al. Effect of chronic administration of ritonavir on function of cytochrome P450 3A and P-glycoprotein in rats. Biol. Pharm. Bull. 2005; 28: 130-7.
25. Hill BA, Brown PC, Preisegger KH, Silverman JA. Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro. Carcinogenesis 1996; 17: 451-7.
26. Pascussi JM, Drocourt L, Gerbal-Chaloin S, Fabre JM, Maurel P, Vilarem MJ. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur. J. Biochem. 2001; 268: 6346-58.
27. Lee CH. Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: Evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated. Mol. Cell Biochem. 2001; 216: 103-10.
28. Hirsch-Ernst KI, Kietzmann T, Ziemann C, Jungermann K, Kahl GF. Physiological oxygen tensions modulate expression of the mdr1b multidrug-resistance gene in primary rat hepatocyte cultures. Biochem. J. 2000; 350: 443-51.
29. Nakatsukasa H, Silverman JA, Gant TW, Evarts RP, Thorgeirsson SS. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology 1993; 18: 1202-7.
30. Ros JE, Roskams TA, Geuken M et al. ATP binding cassette transporter gene expression in rat liver progenitor cells. Gut 2003; 52: 1060-7.
31. Oinonen T, Lindros KO. Zonation of hepatic cytochrome P-450 expression and regulation. Biochem. J. 1998; 329: 17-35.
32. Huang ZH, Murakami T, Okochi A, Yumoto R, Nagai J, Takano M. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur. J. Pharmacol. 2000; 406: 453-60.
33. Ando H, Nishio Y, Ito K et al. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob. Agents Chemother. 2001; 45: 3462-7.
34. Lilja JJ, Niemi M, Neuvonen PJ. Rifampicin reduces plasma concentrations of celiprolol. Eur. J. Clin. Pharmacol. 2004; 59: 819-24.
35. Masereeuw R, Moons MM, Russel FG. Rhodamine 123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation system. Eur. J. Pharmacol. 1997; 321: 315-23.
36. Letteron P, Brahimi-Bourouina N, Robin MA, Moreau A, Feldmann G, Pessayre D. Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation. Am. J. Physiol. 1997; 272: G1141-50.
37. Beier K, Volkl A, Metzger C, Mayer D, Bannasch P, Fahimi HD. Hepatic zonation of the induction of cytochrome P450 IVA, peroxisomal lipid beta-oxidation enzymes and peroxisome proliferation in rats treated with dehydroepiandrosterone (DHEA). Evidence of distinct zonal and sex-specific differences. Carcinogenesis 1997; 18: 1491-8.